The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine Lyme Disease Treatment Drug

The FDA today warned consumers and health care providers not to use an unapproved product called “bismacine” New Lyme Disease Treatment Drug also known as chromacine that’s sometimes used to treat Lyme disease.The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine Lyme Disease Treatment Drug

 

 

.https://medicnewsweb.com/new-lyme-disease-treatment-drug/